These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7684016

  • 21. Interferons in the management of viral hepatitis.
    Zein NN.
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of HBV and HCV antigens expression in correlation with HBV DNA and HCV RNA occurrence in liver biopsy specimens of patients with chronic hepatitis type B and chronic hepatitis type C, respectively.
    Walewska-Zielecka B, Swiderska H, Jończyk M, Nowosławski A.
    Med Sci Monit; 2001 May; 7 Suppl 1():147-50. PubMed ID: 12211710
    [Abstract] [Full Text] [Related]

  • 23. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T.
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [Abstract] [Full Text] [Related]

  • 24. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, Blendis L, Chung SW, Levy GA.
    Transplantation; 1994 Jul 27; 58(2):183-92. PubMed ID: 8042236
    [Abstract] [Full Text] [Related]

  • 25. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ.
    Hepatology; 2002 Jun 27; 35(6):1431-40. PubMed ID: 12029628
    [Abstract] [Full Text] [Related]

  • 26. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
    Suzuki F, Tsubota A, Akuta N, Someya T, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H.
    J Gastroenterol; 2002 Jun 27; 37(11):922-7. PubMed ID: 12483247
    [Abstract] [Full Text] [Related]

  • 27. [Cytokines and hepatitis].
    Degos F.
    Rev Prat; 1993 Mar 01; 43(5):569-73. PubMed ID: 7688135
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    Mifuji R, Kobayashi Y, Ma N, Qiang QL, Urawa N, Horiike S, Iwasa M, Kaito M, Malavasi F, Adachi Y.
    J Gastroenterol Hepatol; 2006 Jan 01; 21(1 Pt 1):144-51. PubMed ID: 16706826
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interferon therapy in hepatitis B virus infection.
    Sheron N, Alexander G, Williams R.
    Recenti Prog Med; 1989 May 01; 80(5):268-70. PubMed ID: 2474844
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Review of the recent advances on interferon and interferon therapy].
    Doğanay M.
    Mikrobiyol Bul; 1983 Jan 01; 17(1):69-73. PubMed ID: 6193401
    [Abstract] [Full Text] [Related]

  • 36. [Predictive factors of response to interferon in chronic hepatitis].
    Forns X, Ampurdanés S.
    Gastroenterol Hepatol; 1995 Jan 01; 18(7):388-95. PubMed ID: 7553278
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Current view on the anti-hepatitis B therapy].
    Guan P, Wang W.
    Zhonghua Yi Xue Za Zhi; 1991 Apr 01; 71(4):234-8. PubMed ID: 1713808
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.